Inventiva

-$0.24 (-1.67%) Today
-$0.05 (-0.35%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can watch Inventiva and buy or sell other stocks, options, and ETFs commission-free!

About IVA

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors.

CEO
Frédéric Cren
Employees
94
Headquarters
Daix, Bourgogne-Franche-Comte
Founded
2011

IVA Key Statistics

Market Cap
545.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.22K
High Today
$14.32
Low Today
$13.51
Open Price
$14.27
Volume
20.47K
52 Week High
$19.06
52 Week Low
$9.01

IVA Earnings

Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Sep 20, After Hours

You May Also Like

AVXL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure